Revive Therapeutics Ltd (RVV.CN)
0.0100 unch (unch) 09:31 ET [CNSX]
0.0050 x 14,660,000 0.0100 x 3,131,000
Realtime by (Cboe BZX)
0.0050 x 14,660,000 0.0100 x 3,131,000
Realtime - - (-) -
for Mon, Jan 27th, 2025
Fiscal Year End Date: 06/30
(Values in thousands)
06-2024 | 06-2023 | 06-2022 | 06-2021 | 06-2020 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 773 | 2,087 | 3,916 | 16,600 | 1,381 |
Marketable Securities | N/A | N/A | N/A | 0 | 100 |
Receivables | 21 | 157 | 191 | 127 | 178 |
Other current assets | 50 | 50 | 0 | 0 | 0 |
TOTAL | $1,141 | $2,352 | $4,164 | $16,795 | $2,158 |
Non-Current Assets | |||||
PPE Net | 1 | 1 | 2 | 2 | 3 |
Investments And Advances | 116 | 163 | 250 | 250 | 250 |
Intangibles | 9,378 | 11,723 | 12,500 | 12,500 | 5,500 |
Other Non-Current Assets | 0 | 13 | 149 | 259 | 349 |
TOTAL | $9,495 | $11,900 | $12,901 | $13,012 | $6,102 |
Total Assets | $10,636 | $14,252 | $17,065 | $29,806 | $8,261 |
Liabilities | |||||
Current Liabilities | |||||
Accounts payable and accrued liabilities | 2,580 | 2,662 | 3,916 | 436 | 210 |
Accrued Expenses | 718 | 639 | 142 | 73 | 92 |
TOTAL | $3,324 | $3,436 | $4,166 | $598 | $372 |
Non-Current Liabilities | |||||
Long Term Debt | N/A | 60 | 60 | 60 | 40 |
aiOther Non-Current Liabilities | 80 | 78 | 77 | 74 | 64 |
TOTAL | $80 | $163 | $296 | $402 | $459 |
Total Liabilities | $3,404 | $3,599 | $4,463 | $1,000 | $832 |
Shareholders' Equity | |||||
Common Shares | 47,500 | 45,980 | 43,113 | 42,430 | 19,126 |
Retained earnings | -66,186 | -60,568 | -54,247 | -36,440 | -16,321 |
Other shareholders' equity | 2,408 | 12,584 | 11,341 | 11,425 | 1,403 |
TOTAL | $7,232 | $10,653 | $12,603 | $28,807 | $7,429 |
Total Liabilities And Equity | $10,636 | $14,252 | $17,065 | $29,806 | $8,261 |